Renalert Overview
- Founded
- 2016

- Status
- Private
- Employees
- 1

- Latest Deal Type
- Grant
- Latest Deal Amount
- $25K

- Investors
- 3
Renalert General Information
Description
Developer of a real time urine analysis device intended to prevent needless deaths due to acute kidney injury. The company's device monitors patient urine, precisely measuring volume, while correlating these values with other vital signs to estimate renal perfusion, incorporates a proprietary algorithm to detect early declines in kidney function, enabling caregivers to detect acute kidney injury in an easy manner and offer treatment accordingly.
Contact Information
- 101 West Dickman Street
- Suite 900
- Baltimore, MD 21230
- United States
Renalert Timeline
Renalert Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Grant | 27-Sep-2019 | $25K | 00000 | Completed | Generating Revenue | |
2. Early Stage VC | 02-Jul-2019 | 00000 | 00000 | Completed | Generating Revenue | |
1. Accelerator/Incubator | 01-Jan-2017 | Completed | Generating Revenue |
Renalert Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Aaron Chang | Founder & Chief Executive Officer |
Renalert Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialRenalert Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Betamore | Accelerator/Incubator | 000 0000 | 000000 0 | ||
TEDCO | Venture Capital | Minority | 000 0000 | 000000 0 | |
Johns Hopkins Technology Ventures | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |